SART3 Antikörper (N-Term)
-
- Target Alle SART3 Antikörper anzeigen
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Ratte, Meerschweinchen, Hund, Pferd, Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SART3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- TSASEPEAES KAGPKADGEE DEVKAARTRR KVLSRAVAAA TYKTMGPAWD
- Homologie
- Dog: 77%, Guinea Pig: 79%, Horse: 79%, Human: 100%, Pig: 86%, Rat: 79%
- Produktmerkmale
- This is a rabbit polyclonal antibody against SART3. It was validated on Western Blot and immunohistochemistry.
- Aufreinigung
- Protein A purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human SART3
- Top Product
- Discover our top product SART3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 364 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma." in: PLoS ONE, Vol. 12, Issue 1, pp. e0170291, (2017) (PubMed).
: "
-
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma." in: PLoS ONE, Vol. 12, Issue 1, pp. e0170291, (2017) (PubMed).
-
- Target
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
- Andere Bezeichnung
- SART3 (SART3 Produkte)
- Synonyme
- SART3 antikoerper, DKFZp469J2418 antikoerper, si:ch211-191d15.4 antikoerper, wu:fc51h03 antikoerper, DSAP1 antikoerper, P100 antikoerper, RP11-13G14 antikoerper, TIP110 antikoerper, p110 antikoerper, p110(nrb) antikoerper, AU045857 antikoerper, mKIAA0156 antikoerper, squamous cell carcinoma antigen recognized by T-cells 3 antikoerper, squamous cell carcinoma antigen recognized by T-cells 3 L homeolog antikoerper, squamous cell carcinoma antigen recognized by T cells 3 antikoerper, SART3 antikoerper, sart3 antikoerper, sart3.L antikoerper, Sart3 antikoerper
- Hintergrund
-
SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing.
Alias Symbols: P100, p110, DSAP1, TIP110, p110(nrb), RP11-13G14
Protein Interaction Partner: APBB1, PRPF3, Usp15, AMOT, SF3B1, NUP160, LRPPRC, THRAP3, BCLAF1, VARS, UBC, SUMO2, RAB1A, NEFM, IARS, HIF1A, DSG2, DHX9, MEPCE, HIST2H2BE, HIST2H2AC, RNF2, BMI1, RUFY1, NRBP1, PSME4, AKAP2, COPS5, NUP50, POP7, ARHGEF10, PSMB3, PSMA5, PSMA3, POLR2H, CAST,
Protein Size: 364 - Molekulargewicht
- 40 kDa
- Gen-ID
- 9733
- NCBI Accession
- NM_014706
- Pathways
- Ribonucleoprotein Complex Subunit Organization
-